These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10807948)

  • 1. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates.
    Astriab-Fisher A; Sergueev DS; Fisher M; Shaw BR; Juliano RL
    Biochem Pharmacol; 2000 Jul; 60(1):83-90. PubMed ID: 10807948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis.
    Fisher AA; Ye D; Sergueev DS; Fisher MH; Shaw BR; Juliano RL
    J Biol Chem; 2002 Jun; 277(25):22980-4. PubMed ID: 11948195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased uptake of antisense oligonucleotides by delivery as double stranded complexes.
    Astriab-Fisher A; Fisher MH; Juliano R; Herdewijn P
    Biochem Pharmacol; 2004 Aug; 68(3):403-7. PubMed ID: 15242806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.
    Kang H; Fisher MH; Xu D; Miyamoto YJ; Marchand A; Van Aerschot A; Herdewijn P; Juliano RL
    Nucleic Acids Res; 2004; 32(14):4411-9. PubMed ID: 15316104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
    Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
    Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.
    Stewart AJ; Canitrot Y; Baracchini E; Dean NM; Deeley RG; Cole SP
    Biochem Pharmacol; 1996 Feb; 51(4):461-9. PubMed ID: 8619891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally modified phosphodiester antisense oligodeoxyribonucleotide directed against the multidrug resistance gene mdr1.
    Brigui I; Djavanbakht-Samani T; Jollès B; Pigaglio S; Laigle A
    Biochem Pharmacol; 2003 Mar; 65(5):747-54. PubMed ID: 12628488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
    Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
    Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. RNA accessibility in vitro and intracellular antisense activity.
    Kostenko EV; Laktionov PP; Vlassov VV; Zenkova MA
    Biochim Biophys Acta; 2002 Jun; 1576(1-2):143-7. PubMed ID: 12031494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression.
    Alahari SK; DeLong R; Fisher MH; Dean NM; Viliet P; Juliano RL
    J Pharmacol Exp Ther; 1998 Jul; 286(1):419-28. PubMed ID: 9655887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene silencing using a conjugate comprising Tat peptide and antisense oligonucleotide with phosphorothioate backbones.
    Maegawa Y; Mochizuki S; Miyamoto N; Sakurai K
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1276-8. PubMed ID: 26774656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-methylphosphonate-modified oligo-2'-O-methylribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture.
    Prater CE; Miller PS
    Bioconjug Chem; 2004; 15(3):498-507. PubMed ID: 15149177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
    Ho SP; Britton DH; Stone BA; Behrens DL; Leffet LM; Hobbs FW; Miller JA; Trainor GL
    Nucleic Acids Res; 1996 May; 24(10):1901-7. PubMed ID: 8657572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides.
    Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R
    Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
    Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
    Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
    Bongartz JP; Aubertin AM; Milhaud PG; Lebleu B
    Nucleic Acids Res; 1994 Nov; 22(22):4681-8. PubMed ID: 7984418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro inhibition properties of oligonucleotide conjugates carrying amphipathic proline-rich peptide derivatives of the sweet arrow peptide (SAP).
    Grijalvo S; Eritja R
    Mol Divers; 2012 May; 16(2):307-17. PubMed ID: 22392648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides.
    Nakagawa O; Ming X; Carver K; Juliano R
    Bioconjug Chem; 2014 Jan; 25(1):165-70. PubMed ID: 24354269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.